Quetiapine

Quetiapine is a second-generation (atypical) antipsychotic that acts on multiple neurotransmitter receptors. Its primary mechanism involves antagonism at serotonin 5-HT2A receptors and dopamine D2 receptors, with relatively loose binding at D2 receptors compared to first-generation antipsychotics ^{[1, 3]}.

This "fast-off" D2 receptor binding is clinically important — it provides antipsychotic efficacy while significantly reducing the risk of extrapyramidal symptoms (EPS) and tardive dyskinesia that plagued older antipsychotics ^{[1, 3, 4]}.

Quetiapine also has significant activity at histamine H1 receptors (causing sedation and weight gain), alpha-1 adrenergic receptors (causing orthostatic hypotension), and muscarinic receptors ^{[1, 3]}.

Its active metabolite, norquetiapine (N-desalkylquetiapine), acts as a potent norepinephrine reuptake inhibitor and partial agonist at 5-HT1A receptors, which likely contributes to quetiapine's unique antidepressant efficacy — it is the only atypical antipsychotic FDA-approved as monotherapy for bipolar depression ^{[1, 3, 5]}.

The CATIE trial (Clinical Antipsychotic Trials of Intervention Effectiveness), one of the largest schizophrenia studies ever conducted, found that quetiapine had comparable efficacy to other atypical antipsychotics but was associated with more sedation and metabolic effects ^[4].

Days 1-7: Start with low doses and titrate. Sedation is often the first and most prominent effect, especially with IR formulations. Orthostatic hypotension may occur — rise slowly from sitting/lying. Dry mouth is common ^[1].

Weeks 1-4: Sedation may partially improve as tolerance develops. Appetite increase and weight gain begin. For schizophrenia, psychotic symptom improvement typically starts within 1-2 weeks. For bipolar depression, mood improvement may begin by week 1-2 ^{[1, 5]}.

Weeks 4-12: Full therapeutic effects are generally evident. Metabolic monitoring should begin — weight, fasting glucose, and lipid panel. Weight gain averages 2-5 kg in the first 12 weeks ^{[1, 4]}.

Long-term: Metabolic syndrome risk increases over time. Regular monitoring of weight, glucose, HbA1c, and lipids is essential. Tardive dyskinesia risk is low but not zero (~0.5-1% per year with atypical antipsychotics) ^{[1, 4]}.

Seroquel XR should be taken without food or with a light meal (less than 300 calories). A high-fat meal increases peak levels by 44-52% for the XR formulation. The IR formulation can be taken with or without food ^[1].

Alcohol: Alcohol should be avoided with quetiapine. Both are CNS depressants, and the combination greatly increases sedation, impairs motor function, and increases fall risk. This is particularly important given quetiapine's already strong sedative effects ^[1].

Grapefruit: Grapefruit juice inhibits CYP3A4 and can increase quetiapine levels. Avoid regular consumption of large amounts of grapefruit or grapefruit juice ^{[1, 3]}.

Caffeine: No direct pharmacokinetic interaction. Caffeine may partially offset sedation but can worsen anxiety in some patients ^[1].

Dosing varies significantly by indication ^[1]:

Schizophrenia (adults): Start 25 mg twice daily; titrate by 25-50 mg per dose over 4+ days. Target: 300-800 mg/day in 2-3 divided doses (IR) or once daily (XR). Usual effective range: 400-800 mg/day ^[1].

Bipolar Mania: Start 50 mg twice daily (IR) or 300 mg once daily (XR on Day 1). Titrate rapidly: usual range 400-800 mg/day by Day 4-6 ^[1].

Bipolar Depression: 50 mg Day 1, 100 mg Day 2, 200 mg Day 3, 300 mg Day 4 and thereafter. Target: 300 mg/day (XR, once daily at bedtime) ^[1].

Adjunctive MDD (with SSRI/SNRI): Start 50 mg/day (XR); increase to 150-300 mg/day. Target: 150-300 mg/day ^[1].

Elderly: Start at 25-50 mg/day; titrate more slowly. Clearance reduced 40% ^[1].

Hepatic impairment: Start at 25 mg/day; titrate slowly. Clearance reduced 30% ^[1].

Generic quetiapine is widely available and costs approximately $10-30/month compared to $600-1200/month for brand-name Seroquel or Seroquel XR ^[1].

Pharmacy discount programs: Generic quetiapine IR is available on $4 generic lists at many major retailers. The XR formulation is slightly more expensive generically ($15-40/month). GoodRx coupons can reduce costs further ^[1].

Patient assistance programs: AstraZeneca (manufacturer) offers the AZ&Me patient assistance program for eligible uninsured patients (azandmeapp.com) ^[1].

Insurance: Generic quetiapine IR is Tier 1 on most formularies. XR may be Tier 2 with a modest copay. Prior authorization may be required for the XR formulation on some plans ^[1].

Split-dosing strategy: For bipolar depression, some clinicians use generic IR tablets at bedtime instead of XR, achieving similar efficacy at lower cost ^[1].

Pregnancy: Quetiapine use during pregnancy has not been associated with a significant increase in major malformations in available studies, though data is more limited than for older medications ^{[1, 10]}. Third-trimester exposure may cause extrapyramidal symptoms and withdrawal in the neonate. Untreated maternal psychotic illness carries its own risks. The decision to continue should involve careful risk-benefit analysis.

Breastfeeding: Quetiapine is excreted in breast milk at low levels (relative infant dose approximately 0.09-0.43% of maternal weight-adjusted dose), making it one of the lowest-transfer atypical antipsychotics ^{[10, 11]}. However, the long-term effects on the developing infant are unknown. Monitor the infant for excessive sedation and developmental milestones.

Bioequivalence: Generic quetiapine IR and XR formulations are FDA AB-rated as bioequivalent to brand Seroquel and Seroquel XR ^[1].

Clinical equivalence: Generic formulations have demonstrated equivalent blood levels and clinical outcomes. The CATIE trial used brand Seroquel, but post-generic observational data confirms equivalent effectiveness ^[4].

Formulation difference: The IR formulation is dosed 2-3 times daily, while XR is once daily. Both generics are significantly cheaper than their brand counterparts ^[1].

Cost: Brand Seroquel: $600-1200/month. Generic quetiapine IR: $10-30/month. Generic quetiapine XR: $15-40/month ^[1].